Literature DB >> 19079193

Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture.

J V Fahey1, J A Wright, L Shen, J M Smith, M Ghosh, R M Rossoll, C R Wira.   

Abstract

The goal of this study was to examine the role of E(2) in regulating innate immune protection by human uterine epithelial cells (UECs). Recognizing that UECs produce cytokines and chemokines to recruit and activate immune cells as well as viral and bacterial antimicrobials, we sought to examine the effect of E(2) on constitutive and Toll-like receptor (TLR) agonist (lipopolysaccharide (LPS) and poly (I:C))-induced immune responses. The secretion by polarized UECs in culture of interleukin (IL)-6, macrophage inhibitory factor (MIF), and secretory leukocyte protease inhibitor (SLPI) was examined as well as the mRNA expression of human beta-defensin-2 (HBD2), tumor necrosis factor (TNF)-alpha, IL-8, and nuclear factor (NF)-kB. When incubated with E(2) for 24-48 h, we found that E(2) stimulated UEC secretion of SLPI (fourfold) and mRNA expression of HBD2 (fivefold). Moreover, when antibacterial activity in UEC secretions was measured using Staphylococcus aureus, E(2) increased the secretion of soluble factor(s) with antibacterial activity. In contrast, E(2) had no effect on constitutive secretion of proinflammatory cytokines and chemokines by UECs but completely inhibited LPS- and poly (I:C)-induced secretion of MIF, IL-6, and IL-8. Estradiol also reversed the stimulatory effects of IL-1beta on mRNA expression of TNF-alpha, IL-8, and NF-kB by 85, 95, and 70%, respectively. As SLPI is known to inhibit NF-kB expression, these findings suggest that E(2) inhibition of proinflammatory cytokines may be mediated through SLPI regulation of NF-kB. Overall, these findings indicate that the production of cytokines, chemokines, and antimicrobials by UECs are differentially regulated by E(2). Further, it suggests that with E(2) regulation, epithelial cells that line the uterine cavity have evolved immunologically to be sensitive to viral and bacterial infections as well as the constraints of procreation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079193      PMCID: PMC4815904          DOI: 10.1038/mi.2008.20

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  57 in total

1.  Defensins and host defense.

Authors:  T Ganz
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.

Authors:  A J Quayle; E M Porter; A A Nussbaum; Y M Wang; C Brabec; K P Yip; S C Mok
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion.

Authors:  A B Lentsch; H Yoshidome; R L Warner; P A Ward; M J Edwards
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.

Authors:  H Hocini; P Becquart; H Bouhlal; H Adle-Biassette; M D Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

5.  17beta-estradiol inhibits the production of RANTES in human keratinocytes.

Authors:  Naoko Kanda; Shinichi Watanabe
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

6.  Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium.

Authors:  Anne E King; Diana C Fleming; Hilary O D Critchley; Rodney W Kelly
Journal:  J Reprod Immunol       Date:  2003-06       Impact factor: 4.054

7.  Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.

Authors:  De Yang; Qian Chen; David M Hoover; Patricia Staley; Kenneth D Tucker; Jacek Lubkowski; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2003-09       Impact factor: 4.962

8.  Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.

Authors:  A B Lentsch; J A Jordan; B J Czermak; K M Diehl; E M Younkin; V Sarma; P A Ward
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

9.  17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.

Authors:  Margaret J Lesmeister; Rebecca L Jorgenson; Steven L Young; Michael L Misfeldt
Journal:  Reprod Biol Endocrinol       Date:  2005-12-29       Impact factor: 5.211

10.  Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.

Authors:  Akira Nakamura; Yuriko Mori; Koichi Hagiwara; Takuji Suzuki; Tomohiro Sakakibara; Toshiaki Kikuchi; Takayuki Igarashi; Masahito Ebina; Tatsuya Abe; Junichi Miyazaki; Toshiyuki Takai; Toshihiro Nukiwa
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  55 in total

1.  Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix.

Authors:  Lyndsey R Buckner; Danny J Schust; Jian Ding; Takeshi Nagamatsu; Wandy Beatty; Theresa L Chang; Sheila J Greene; Maria E Lewis; Bernardo Ruiz; Stacey L Holman; Rae Ann Spagnuolo; Richard B Pyles; Alison J Quayle
Journal:  J Reprod Immunol       Date:  2011-09-22       Impact factor: 4.054

Review 2.  Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors.

Authors:  B Dunbar; M Patel; J Fahey; C Wira
Journal:  Mol Cell Endocrinol       Date:  2012-01-25       Impact factor: 4.102

Review 3.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

Review 4.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

Review 5.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

Review 6.  Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2012-10-04       Impact factor: 3.886

7.  Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells.

Authors:  Severina N Haddad; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

8.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Specific strains of Escherichia coli are pathogenic for the endometrium of cattle and cause pelvic inflammatory disease in cattle and mice.

Authors:  I Martin Sheldon; Andrew N Rycroft; Belgin Dogan; Melanie Craven; John J Bromfield; Alyssa Chandler; Mark H Roberts; Sian B Price; Robert O Gilbert; Kenneth W Simpson
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

Review 10.  Fertile ground: human endometrial programming and lessons in health and disease.

Authors:  Jemma Evans; Lois A Salamonsen; Amy Winship; Ellen Menkhorst; Guiying Nie; Caroline E Gargett; Eva Dimitriadis
Journal:  Nat Rev Endocrinol       Date:  2016-07-22       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.